Share
New Offering: huSyngeneic Screen

Human Transgenic MC38 Syngeneic System

ENROLLMENT OPEN NOW THROUGH November 30th


Enrollment in this study is now open on a first-come first-served basis.


Sample data detailing responses to Keytruda is shown below:
The details on Champions' MC38 huSyngeneic screen are discussed below:
  • Full knock-out of murine targets.
  • Endogenous expression of human targets.
  • The model has been characterized for Keytruda Response
  • FREE Vehicle response data
  • 50% off Keytruda data
  • Limited enrollment available on a first come-first served basis
  • Enrollment open now through Novemeber 30th.
Please contact Anna Amcheslavsky today at aamcheslavsky@championsoncology.com or 575-571-8531 for more information

Email Marketing by ActiveCampaign